Reduced CSF carboxyterminally truncated Aβ peptides in frontotemporal lobe degenerations

Journal of Neural Transmission

Volumn 114, Issue 5, 2007, Pages 621-628

  Bibl, M ^a   Mollenhauer, B ^b   Wolf, S ^b   Esselmann, H ^c   Lewczuk, P ^c   Kornhuber, J ^c   Wiltfang, J ^c  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Alzheimer's disease; Amyloid peptides; Biomarkers; Cerebrospinal fluid; Frontotemporal degeneration

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-37]; AMYLOID BETA PROTEIN[1-38]; AMYLOID BETA PROTEIN[1-42]; BIOLOGICAL MARKER; TAU PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FRONTOTEMPORAL LOBE DEGENERATION; HUMAN; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN METABOLISM; TEMPORAL LOBE; VALIDATION PROCESS;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; BIOLOGICAL MARKERS; CEREBROSPINAL FLUID PROTEINS; DEMENTIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOBLOTTING; MALE; PEPTIDE FRAGMENTS; PEPTIDES; PREDICTIVE VALUE OF TESTS; PROTEIN STRUCTURE, TERTIARY; TAU PROTEINS;

EID: 34247485829     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-006-0618-z     Document Type: Article

References (34)

1. 40 CSF concentrations correlate to frontal lobe atrophy in frontotemporal dementia Neuroreport 11 287 290
2. N Andreasen L Minthon P Davidsson E Vanmechelen H Vanderstichele B Winblad K Blennow 2001 Evaluation of CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer disease in clinical practice Arch Neurol 58 373 379
3. SE Arnold LY Han CM Clark M Grossman JQ Trojanowski 2000 Quantitative neurohistological features of frontotemporal degeneration J Struct Biol 130 271 279
4. M Bibl H Esselmann M Otto P Lewczuk L Cepek E Rüther J Kornhuber J Wiltfang 2004 Cerebrospinal fluid (CSF) amyloid beta (Aβ) peptide patterns in Alzheimer's disease (AD) patients and non-demented controls depend on sample pre-treatment: indication of carrier-mediated epitope masking of Aβ peptides Electrophoresis 25 2912 2918
5. M Bibl B Mollenhauer H Esselmann HW Klafki K Sparbier A Smirnov L Cepek P Lewczuk C Trenkwalder E Rüther J Kornhuber M Otto J Wiltfang 2006a CSF amyloid-β-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia Brain 129 1177 1187
6. M Bibl B Mollenhauer H Esselmann P Lewczuk C Trenkwalder P Brechlin E Rüther J Kornhuber M Otto J Wiltfang 2006b CSF diagnosis of Alzheimer's disease and dementia with Lewy bodies J Neural Transm 113 11 1771 1778
7. K Blennow 2004 Cerebrospinal fluid protein biomarkers for Alzheimer's disease NeuroRx 1 213 225
8. K Blennow A Wallin H Agren C Spenger J Siegfried E Vanmechelen 1995 Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer's disease Mol Chem Neuropathol 26 231 245
9. M Citron TS Diehl G Gordon AL Biere P Seubert DJ Selkoe 1996 Evidence that the 42- and 40-amino acid forms of amyloid beta protein are generated from the beta-amyloid precursor protein by different protease activities Proc Natl Acad Sci USA 93 13170 13175
10. B Dermaut S Kumar-Singh S Engelborghs J Theuns R Rademakers J Saerens BA Pickut K Peeters M van der Broeck K Vennekens S Claes M Cruts P Cras JJ Martin C Van Broeckhoven PP De Deyn 2004 A novel presenilin 1 mutation associated with Pick's disease but not β-amyloid plaques Ann Neurol 55 617 626
11. D Galasko K Marder 2002 Picking away at frontotemporal dementia Neurology 58 1585 1586
12. GG Glenner CW Wong 1984 Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein Biochem Biophys Res Commun 120 885 890
13. A Green R Harvey E Thompson M Rossor 1999 Increased tau in the cerebrospinal fluid of patients with frontotemporal dementia and Alzheimer's disease Neurosci Lett 259 133 135
14. M Grossman J Farmer S Light M Work P Moore V Van Deerlin D Pratico CM Clark HB Coslett A Chatterjee J Gee JQ Trojanowski VM Lee 2005 Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease Ann Neurol 57 721 729
15. C Haas DJ Selkoe 1993 Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide Cell 75 1039 1042
16. F Hulstaert K Blennow A Ivanoiu HC Schoonderwald M Riemenschneider PP De Deyn C Bancher P Cras J Wiltfang PD Mehta K Iqbal H Pottel E Vanmechelen H Vanderstichele 1999 Improved discrimination of AD-patients using β-amyloid (1-42) and tau levels in CSF Neurology 52 1555 1562
17. K Janek S Rothemund K Gast M Beyermann J Zipper H Fabian M Bienert E Krause 2001 Study of the conformational transition of A beta(1-42) using D-amino acid replacement analogues Biochemistry 40 5457 5463
18. AR Koudinov NV Koudinova A Kumar RC Beavis J Ghiso 1996 Biochemical characterization of Alzheimer's soluble amyloid beta protein in human cerebrospinal fluid: association with density lipoproteins Biochm Biophys Res Commun 223 592 597
19. G McKhann D Drachman M Folstein R Katzman D Price EM Stadlan 1984 Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 939 944
20. GM McKhann MS Albert M Grossman B Miller D Dickson JQ Trojanowski Work Group on Frontotemporal Dementia and Pick's Disaese 2001 Clinical and pathological diagnosis of frontotemporal dementia. Report of the work group on frontotemporal dementia and Pick's disease Arch Neurol 58 1803 1809
21. (1-42) and S100B protein in cerebrospinal fluid of patients with Dementia with Lewy Bodies Dement Cogn Geriatr Disord 19 164 170
22. D Neary JS Snowden L Gustafson U Passant D Stuss S Black M Freedman A Kertesz PH Robert M Albert K Boone BL Miller J Cummings DF Benson 1998 Frontotemporal lobardegeneration. A consensus on clinical diagnostic criteria Neurology 51 1546 1554
23. M Pitschke R Prior M Haupt D Riesner 1998 Detection of single amyloid beta-protein aggregates in the cerebrospinal fluid of Alzheimer's patients by fluorescence correlation spectroscopy Nat Med 4 832 834
24. MB Podlisny BL Ostaszewski SL Squazzo EH Koo RE Rydell DB Teplow DJ Selkoe 1995 Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture J Biol Chem 270 9564 9570
25. M Riemenschneider S Wagenpfeil J Diehl N Lautenschlager T Theml B Heldmann A Drzezga T Jahn H Förstl A Kurz 2002 Tau and Aβ42 protein in CSF of patients with frontotemporal degeneration Neurology 58 1622 1628
26. 1-42 and GAP-43 in frontotemporal dementia, other types of dementia and normal aging J Neural Transm 107 563 579
27. M Sjögren L Rosgren L Minthon P Davidson K Blennow A Wallin 2000b Cytoskeleton proteins in CSF distinguishfrontotemporal dementia from AD Neurology 54 1960 1964
28. M Sjögren P Davidsson M Tullberg L Minthon A Wallin C Wikkelso AK Granerus H Vanderstichele E Vanmechelen K Blennow 2001 Both total and phosphorylated tau are increased in Alzheimer's disease J Neurol Neurosurg Psychiatry 70 624 630
29. MM Verbeek D de Jong HPH Kremer 2003 Brain-specific proteins in cerebrospinal fluid for the diagnosis of neurodegenerative diseases Ann Clin Biochem 40 25 40
30. J Wiltfang H Esselmann P Cupers M Neumann H Kretzschmar M Beyermann D Schleuder H Jahn E Rüther J Kornhuber W Annaert B De Strooper P Saftig 2001 Elevation of beta-amyloid peptide 2-42 in sporadic and familial Alzheimer's disease and its generation in PS1 knockout cells J Biol Chem 276 42645 42657
31. J Wiltfang H Esselmann M Bibl A Smirnov M Otto S Paul B Schmid H-W Klafki M Maler T Dyrks M Bienert M Beyermann E Rüther J Kornhuber 2002 Highly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and patients with chronic neuroinflammation J Neurochem 81 481 496
32. J Wiltfang H Esselmann A Smirnov M Bibl L Cepek P Steinacker B Mollenhauer K Buerger H Hampel S Paul M Neumann M Maler J Kornhuber HA Kretzschmar S Poser M Otto 2003 Beta-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease Ann Neurol 54 263 267
33. J Wiltfang P Lewczuk P Riederer E Grunblatt C Hock P Scheltens H Hampel H Vanderstichele K Iqbal D Galasko L Lannfelt M Otto H Esselmann AW Henkel J Kornhuber K Blennow 2005 Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia World J Biol Psychiatry 6 69 84
34. World Medical Organisation 1996 Declaration of Helsinki Bri Med J 313 1448 1449